Paper21746941
In vitro destruction of Streptococcus pneumoniae biofilms with bacterial and phage peptidoglycan hydrolases.
Domenech M and 2 others. Antimicrob Agents Chemother, 2011. Cited by 72 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. In vitro destruction of Streptococcus pneumoniae biofilms with bacterial and phage peptidoglycan hydrolases. Papers, record 21746941. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21746941
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In vitro destruction of Streptococcus pneumoniae biofilms with bacterial and phage peptidoglycan hydrolases.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biofilms | Major topic |
| N-Acetylmuramoyl-L-alanine Amidase | Major topic |
| Streptococcus oralis | Major topic |
| Streptococcus pneumoniae | Major topic |
| Cell Wall |
Source PubMed
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5,432,063 | Cleavage of structural proteins during the assembly of the head of bacteriophage T4. | Nature | 1970 | https://conductscience.org/library/papers/5432063 | PubMed |
| 2 | 20,452,280 | Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens. | Int J Med Microbiol | 2010 | https://conductscience.org/library/papers/20452280 | PubMed |
| 3 | 20,810,181 | Bacteriophages as potential new therapeutics to replace or supplement antibiotics. | Trends Biotechnol | 2010 | https://conductscience.org/library/papers/20810181 | PubMed |
| 4 | 9,379,901 | The lytic enzyme of the pneumococcal phage Dp-1: a chimeric lysin of intergeneric origin. | Mol Microbiol | 1997 | https://conductscience.org/library/papers/9379901 | PubMed |
| 5 | 9,124,823 | Correlation of pharmacodynamic parameters of five beta-lactam antibiotics with therapeutic efficacies in an animal model. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/9124823 | PubMed |
| 6 | 11,544,234 | Genome of the bacterium Streptococcus pneumoniae strain R6. | J Bacteriol | 2001 | https://conductscience.org/library/papers/11544234 | PubMed |
| 7 | 1,672,313 | Chimeric pneumococcal cell wall lytic enzymes reveal important physiological and evolutionary traits. | J Biol Chem | 1991 | https://conductscience.org/library/papers/1672313 | PubMed |
| 8 | 6,472 | Purification of the pneumococcal N-acetylmuramyl-L-alanine amidase to biochemical homogeneity. | J Biol Chem | 1976 | https://conductscience.org/library/papers/6472 | PubMed |
| 9 | 1,351,240 | Studies on the structure and function of the N-terminal domain of the pneumococcal murein hydrolases. | Mol Microbiol | 1992 | https://conductscience.org/library/papers/1351240 | PubMed |
| 10 | 19,898,768 | The pneumococcus: why a commensal misbehaves. | J Mol Med (Berl) | 2010 | https://conductscience.org/library/papers/19898768 | PubMed |
| 11 | 8,561,477 | Microbial biofilms. | Annu Rev Microbiol | 1995 | https://conductscience.org/library/papers/8561477 | PubMed |
| 12 | 18,221,176 | Novel approaches to fight Streptococcus pneumoniae. | Recent Pat Antiinfect Drug Discov | 2007 | https://conductscience.org/library/papers/18221176 | PubMed |
| 13 | 19,162,482 | Preventing biofilms of clinically relevant organisms using bacteriophage. | Trends Microbiol | 2009 | https://conductscience.org/library/papers/19162482 | PubMed |
| 14 | 17,827,138 | In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains. | J Antimicrob Chemother | 2007 | https://conductscience.org/library/papers/17827138 | PubMed |
| 15 | 14,613,958 | Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model. | J Antimicrob Chemother | 2003 | https://conductscience.org/library/papers/14613958 | PubMed |
| 16 | 14,413,322 | A study of the genetic material determining an enzyme in Pneumococcus. | Biochim Biophys Acta | 1960 | https://conductscience.org/library/papers/14413322 | PubMed |
| 17 | 17,085,695 | Lytic activity of recombinant bacteriophage phi11 and phi12 endolysins on whole cells and biofilms of Staphylococcus aureus. | Appl Environ Microbiol | 2007 | https://conductscience.org/library/papers/17085695 | PubMed |
| 18 | 7,903,254 | Role of the C-terminal domain of the lysozyme of Clostridium acetobutylicum ATCC 824 in a chimeric pneumococcal-clostridial cell wall lytic enzyme. | FEBS Lett | 1993 | https://conductscience.org/library/papers/7903254 | PubMed |
| 19 | 17,381,239 | Novel strategy to prevent otitis media caused by colonizing Streptococcus pneumoniae. | PLoS Pathog | 2007 | https://conductscience.org/library/papers/17381239 | PubMed |
| 20 | 15,539,074 | Recent trends on the molecular biology of pneumococcal capsules, lytic enzymes, and bacteriophage. | FEMS Microbiol Rev | 2004 | https://conductscience.org/library/papers/15539074 | PubMed |
Cited by47
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 72 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,041,333 | Inhibition of Biofilm Formation by Respiratory Bacterial Pathogens via Silver Nanoparticles and Functionalized HEPA Filters. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/42041333 | PubMed |
| 40,742,145 | Streptococcus pneumoniae β-lactam resistance: epidemiological trends, molecular drivers, and innovative control strategies in the post-pandemic era. | Clin Microbiol Rev | 2025 | https://conductscience.org/library/papers/40742145 | PubMed |
| 40,351,404 | Degradation of Preformed Gram-Positive and Gram-Negative Bacterial Biofilms Using Disintegrated and Intact Phages. | Phage (New Rochelle) | 2025 | https://conductscience.org/library/papers/40351404 | PubMed |
| 40,284,663 | Structure, Function, and Regulation of LytA: The N-Acetylmuramoyl-l-alanine Amidase Driving the "Suicidal Tendencies" of Streptococcus pneumoniae-A Review. | Microorganisms | 2025 | https://conductscience.org/library/papers/40284663 | PubMed |
| 39,555,077 | PCV13 vaccine prevents pneumococcal biofilms without affecting Staphylococcus aureus population within the polymicrobial biofilm. | Front Immunol | 2024 | https://conductscience.org/library/papers/39555077 | PubMed |
| 38,987,594 | An enterococcal phage-derived enzyme suppresses graft-versus-host disease. | Nature | 2024 | https://conductscience.org/library/papers/38987594 | PubMed |
| 38,693,045 | Research Progress on Strategies for Improving the Enzyme Properties of Bacteriophage Endolysins. | J Microbiol Biotechnol | 2024 | https://conductscience.org/library/papers/38693045 | PubMed |
| 38,470,268 | SP-CHAP, an endolysin with enhanced activity against biofilm pneumococci and nasopharyngeal colonization. | mBio | 2024 | https://conductscience.org/library/papers/38470268 | PubMed |
| 37,551,971 | The choline-binding proteins PspA, PspC, and LytA of Streptococcus pneumoniae and their interaction with human endothelial and red blood cells. | Infect Immun | 2023 | https://conductscience.org/library/papers/37551971 | PubMed |
| 37,436,548 | Integration of Lysin into Chitosan Nanoparticles for Improving Bacterial Biofilm Inhibition. | Appl Biochem Biotechnol | 2024 | https://conductscience.org/library/papers/37436548 | PubMed |
| 36,198,381 | Meta-analysis of fecal viromes demonstrates high diagnostic potential of the gut viral signatures for colorectal cancer and adenoma risk assessment. | J Adv Res | 2023 | https://conductscience.org/library/papers/36198381 | PubMed |
| 36,139,994 | The Mechanism of Bacterial Resistance and Potential Bacteriostatic Strategies. | Antibiotics (Basel) | 2022 | https://conductscience.org/library/papers/36139994 | PubMed |
| 35,210,792 | How Good are Bacteriophages as an Alternative Therapy to Mitigate Biofilms of Nosocomial Infections. | Infect Drug Resist | 2022 | https://conductscience.org/library/papers/35210792 | PubMed |
| 34,943,709 | Treating Bacterial Infections with Bacteriophage-Based Enzybiotics: In Vitro, In Vivo and Clinical Application. | Antibiotics (Basel) | 2021 | https://conductscience.org/library/papers/34943709 | PubMed |
| 34,869,076 | Streptococcus pneumoniae: a Plethora of Temperate Bacteriophages With a Role in Host Genome Rearrangement. | Front Cell Infect Microbiol | 2021 | https://conductscience.org/library/papers/34869076 | PubMed |
| 34,827,215 | Endolysin, a Promising Solution against Antimicrobial Resistance. | Antibiotics (Basel) | 2021 | https://conductscience.org/library/papers/34827215 | PubMed |
| 34,777,288 | Structural and Functional Insights Into Skl and Pal Endolysins, Two Cysteine-Amidases With Anti-pneumococcal Activity. Dithiothreitol (DTT) Effect on Lytic Activity. | Front Microbiol | 2021 | https://conductscience.org/library/papers/34777288 | PubMed |
| 33,356,690 | Ways to control harmful biofilms: prevention, inhibition, and eradication. | Crit Rev Microbiol | 2021 | https://conductscience.org/library/papers/33356690 | PubMed |
| 33,352,708 | A New Phage Lysin Isolated from the Oral Microbiome Targeting Streptococcus pneumoniae. | Pharmaceuticals (Basel) | 2020 | https://conductscience.org/library/papers/33352708 | PubMed |
| 33,204,659 | Characterization of MSlys, the endolysin of Streptococcus pneumoniae phage MS1. | Biotechnol Rep (Amst) | 2020 | https://conductscience.org/library/papers/33204659 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| PGLYRP2 | 114,770 | PubTator's text mining | https://conductscience.org/library/genes/114770 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21746941
GET https://conductscience.org/api/papers/v1/21746941/references?page=2